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Adherence to cardiac medications makes a significant contribution to avoidance of morbidity 
and premature mortality in patients with cardiovascular disease. This quantitative study 
employed cross-sectional survey design to evaluate medication adherence and contributing 
factors among patients with cardiovascular disease, comparing patients who were admitted to 
a cardiac ward (n=89) and those attending outpatient cardiac rehabilitation (n=31) in Australia. 
Data collection was completed between October 2016 and December 2017. Descriptive and 
regression analyses were conducted to identify medication adherence and determine factors 
independently predictive of medication adherence. Participants from cardiac rehabilitation had 
significantly lower adherence to cardiac medications than those recruited from the cardiac ward 
(58.1% vs. 64.0% respectively). Self-efficacy was significantly associated with participants’ 
medication adherence in both groups. The ability to refill medications and beliefs about cardiac 
medications were independently significantly predictive of cardiac medication adherence. 
These findings indicate areas where clinical nurses could expand their role to improve cardiac 
patients’ medication self-management. 
Keywords: Beliefs, medication adherence, cardiovascular disease, cardiac rehabilitation, 
predictive factors, medication refill, nursing, self-efficacy.   
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1. Introduction  
Cardiovascular disease (CVD) is a major cause of mortality and disability worldwide, 
and was the main cause of mortality in 2017 in Australia, accounting for 10,514 (13%) and 
8,076 (10%) deaths among male and female, respectively (Australian Institute of Health and 
Welfare, 2019). Adherence to cardio-protective medications is critical for primary and 
secondary prevention of CVD, but it is estimated that up to 50% of medications are not taken 
as prescribed by patients with chronic disease, increasing rehospitalization rates and premature 
mortality (Burnier & Egan, 2019).  
The World Health Organization defines adherence to medications as “taking more than 
eighty percent of medicines as prescribed” (Sabaté, 2003, p. 3). Medication adherence typically 
decreases over time; this is a major challenge in all chronic diseases (Usherwood, 2017). For 
instance, a Canadian study found that only thirty-six percent of elderly patients with CVD 
adhered to their cholesterol-related treatments two years after diagnosis (Jackevicius, 
Mamdani, & Tu, 2002). An American study found that 10% -25% of patients newly diagnosed 
with cardiac disease had stopped taking their medications by their 24 week follow-up (Sokol, 
McGuigan, Verbrugge, & Epstein, 2005). In Australia, cardiovascular medication non-
adherence rates ranged between 14% and 43% from 2010 to 2014 (McKenzie, McLaughlin, 
Clark, & Doi, 2015). Despite the increasing potential for cardiac medications to impact 
patients’ health, the level of medication adherence in patients with CVD remains problematic 
(Leslie, Pell, & Mccowan, 2018). For example, a recent RCT conducted in Australia showed 
medication adherence among patients with CVD ranging from only 18.8% to 29.4% for 
intervention and control groups, respectively (Santo et al., 2019). Poor adherence to medication 
regimens in patients with CVD is associated with frequent rehospitalization and mortality (Al‐
Ganmi, Perry, Gholizadeh, & Alotaibi, 2016). Given that medication adherence is an important 
health behavior world-wide, at all points in the treatment of CVD, it is essential to determine 
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adherence to cardio-protective medications and potential predictive factors to initiate 
behavioral changes as needed.  
1.1 Literature review 
Adherence to medication prescriptions is necessary to receive the full benefits of 
medications, but is a complex and dynamic process. This is particularly challenging for patients 
with CVD who are predominantly discharged from hospital with long-term polypharmacy 
(Pandey, Clarus, & Choudhry, 2018). Multiple factors may be influential, including patient-
related behaviors that are difficult to objectively measure and monitor (Boudreaux, Baumann, 
Camargo, O'Hea, & Ziedonis, 2007). Patient knowledge or understanding of a medication 
regimen, perceived adherence barriers or facilitators, low self-efficacy, and lack of belief in the 
necessity of medicines may influence medication adherence (Morrison et al., 2015). 
Socio-demographic factors are relevant. Studies of age have returned inconsistent results: 
while some found those over 65 years particularly non-adherent, possibly because of cognitive 
impairment, physical disability and lack of social support (Pamboukian et al., 2008), others 
found older patients more likely to be adherent than younger patients (Park, Howie-Esquivel, 
Whooley, & Dracup, 2015). Gender may affect medication adherence (Gazmararian et al., 
2006), but again findings are contradictory, perhaps because of the potential for error in self 
reporting, which may produce spurious results. Low medication adherence has been found to 
occur in more male than female patients with CVD and heart failure (Viana et al., 2014). By 
contrast, female patients with CVD were shown to be less likely to adhere to cardioprotective 
regimens than males (Kolandaivelu, Leiden, Gara, & Bhatt, 2014). On the other hand, Doll et 
al. (2015) found neither age nor gender were linked to medication non-adherence in patients 
with CVD attending cardiac rehabilitation. Ethnicity has been shown with similarly 
inconsistent results but has been reported as predictive of medication adherence among patients 
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with myocardial infarction (Zhang, Baik, Chang, Kaplan, & Lave, 2012). Employment status 
has also been found to have an effect, with higher medication non-adherence rates from 
unemployed people, particularly those without healthcare coverage (Lee et al., 2013). 
Other influences include health literacy, where poor literacy has been linked to reduced 
medication adherence (Gazmararian et al., 2006). Social support has generally been linked to 
better medication adherence, positively affecting CVD outcomes (Wu et al., 2013). One 
observational study found that 59.2% of patients with CVD attending cardiac rehabilitation 
with support from family and staff were adherent and better able to refill cardiac medications 
than those with no support (Molloy, Perkins-Porras, Bhattacharyya, Strike, & Steptoe, 2008). 
Mood has also been shown to influence patients’ self-efficacy, their beliefs about medications, 
and medication adherence (Cha, Erlen, Kim, Sereika, & Caruthers, 2008).  
The problem of medication non-adherence has been repeatedly reported among patients 
with various chronic diseases, and disease stages (Park, Seo, Yoo, & Lee, 2018). Cardiac 
patients experience a number of stages in their disease progression and treatment, including 
acute events and hospital admissions, referrals and attendance at cardiac rehabilitation and 
community self-management (Doucette, 2017). Admission to hospital for an acute health event 
has been associated with changes favoring more health-oriented behaviors even in the absence 
of any specific health behavioral intervention (Boudreaux et al., 2007). Among patients 
attending cardiac rehabilitation, self-efficacy and beliefs about the benefits of exercise have 
been associated with medication adherence (Pandey et al., 2018). Few studies consider 
differences in medication adherence among patients with CVD at different stages of treatment, 
although such information could be used to develop strategies for different stages. Investigating 
the dynamics of medication non-adherence may identify specific factors at specific points, 
offering the potential to enhance medication adherence at different stages (King-Shier et al., 
2017). Two such pivotal points in CVD are when an acute event leads to hospitalization, and 
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subsequent rehabilitation. There has been no evaluation of the factors leading to medication 
non-adherence at either stage. Overall, poor medication adherence remains a significant 
challenge in the management of patients with chronic diseases, including those with CVD, with 
a wide, locally relevant but broadly inconsistent variety of predictive factors. The underlying 
conceptual framework of medication adherence and factors that affect patients’ adherence to 
their prescribed medications warrant further exploration.   
1.2 Study aim 
This study aimed to evaluate medication adherence and contributing factors among 
patients with CVD and to compare these between patients admitted to a cardiac ward and those 
attending cardiac rehabilitation in Australia.  
2. Methods  
2.1 Design 
This study is part of a larger study exploring medication non-adherence among patients 
with CVD, part of which has been published (Al-Ganmi, Perry, Gholizadeh, & Alotaibi, 2018). 
In brief, this quantitative study used cross-sectional survey design to examine self-reported 
medication adherence and factors potentially predictive of medication adherence in two groups 
of patients with CVD with a history of prescribed cardiac medications. One group had been 
admitted to hospital for acute conditions such as acute coronary syndrome and 
revascularization interventions; the other was attending cardiac rehabilitation after discharge 
from hospital following similar acute cardiac conditions. Potentially predictive factors included 
beliefs about medication, medication adherence self-efficacy, social support and the ability to 
refill medication. Two stages in the disease trajectory, the acute phase and rehabilitation, were 
chosen to determine if patterns of stage-specific predictive factors could be identified, which 
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might lead to development of targeted nurse-led interventions to improve medication adherence 
at each stage. 
2.2 Participants, sampling and sample size 
Participants were patients with cardiac disease who were admitted to a hospital in Sydney 
for an acute cardiac event such as myocardial infarction or percutaneous coronary intervention, 
or who had been referred to and attended a cardiac rehabilitation program (Al-Ganmi et al., 
2018). The acute cardiac patient population of the hospital comprised approximately 125 
patients with CVD admitted per month to the cardiac ward, with 18% uptake of referrals to the 
cardiac rehabilitation centre (unpublished hospital data). The inclusion criteria specified adults 
aged 18 years and above with a diagnosis of CVD, currently treated with one or more cardiac 
medicines and personally responsible for taking them, prior to hospital admission or when 
attending cardiac rehabilitation. Participants needed to understand written and spoken English 
to complete the survey. Patients with vision and hearing impairment, cognitively impaired 
patients, those with history of psychiatric diseases, and patients who were not taking any 
cardiac medication were excluded (See Appendix 1).  
A sample size of 85 participants was calculated to demonstrate a moderate sized effect 
(α = 0.05, 5% level of significance) and power = 0.80 based on medication adherence as 
reported by Ma, Zhou, Zhou, and Huang (2014) and calculated based on a formula  by 
Viechtbauer et al. (2015). Taking into account the possibility of as much as 50% non-response 
or incomplete response, given the busy clinical environments in which recruitment occurred, 
the sample was increased to 129 participants. In total, 120 participants were recruited.  
2.3 Study setting 
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The study setting was one hospital in Sydney, Australia, which has in-patient diagnostic 
and interventional cardiac services including a cardiothoracic intensive care and sub-acute 
surgical ward, and a coronary care and sub-acute cardiology ward.   
2.3.1 Routine medication care 
The Australian Cardiac Rehabilitation Association recommends that routine care for 
cardiac patients should include: education on the importance of adherence to cardiovascular 
medicines including the reasons for their use, barriers to medication adherence, medication 
doses and frequency, and monitoring medication adherence using a tested tool (Woodruffe et 
al., 2014). Nurses and pharmacists are mainly responsible for providing medication education 
to patients with CVD during their stay in the cardiac ward and as a part of their cardiac 
rehabilitation.  
2.4 Ethical considerations  
The study was approved by the relevant health services and university human research 
ethic committees (reference numbers:16/085-HREC/16/POWH/218; ETH16-0635).  
2.5 Data collection 
Between October 2016 and December 2017, 120 completed questionnaires were obtained 
from 89 in-patients and 31 out-patients (Appendix 1). For in-patients, the questions referred to 
medication adherence in the period immediately prior to hospital admission. Data collection 
took place in the cardiac ward for in-patients, and during attendance at cardiac rehabilitation in 
the waiting room. 
2.5.1 Study instruments  
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The survey comprised questionnaires about patients’ adherence to cardiac medication, 
their beliefs, behavioral and psychological factors linked with medication non-adherence in 
previous studies (Horne, Weinman, & Hankins, 1999; Morisky, Green, & Levine, 1986), 
identified as potentially predictive of medication adherence and offering opportunities for 
nurse-led interventions to enhance adherence. The survey was piloted with five participants; 
no problems were identified. Completion took 10-15 minutes. The language was deemed 
manageable for those with poor literacy skills.  
2.5.1.1 Sociodemographic and health-related factors 
Data collected in this section included: age (years), gender (male, female), employment 
status (employed, unemployed, retired), living arrangement (lives alone or with 
spouse/partner/others), marital status (married/co-habiting or not in a relationship). It also 
asked for years of full-time education, ethnic background (Australian/New Zealander, others), 
presence of co-morbidities such as hypertension, diabetes mellitus, respiratory or renal disease, 
and number of cardiac medications taken daily. Co-morbidities were included because 
increasing numbers of diseases are linked to increasing numbers of medications and both have 
been linked to medication adherence. Comorbidities comprised kidney disease, respiratory 
disease and diabetes mellitus. Diabetes was identified separately because of the high 
occurrence and high burden of medication management of this disease in people with CVD. 
2.5.1.2 Questionnaires addressing medication adherence  
The validity and reliability of the study instruments to detect medication non-adherent 
behaviors in patients with CVD in various cardiac settings have been established (Al-Ganmi et 
al., 2018). The Medication Adherence Questionnaire (MAQ) (Morisky et al., 1986) is a four-
item scale used to assess medication adherence and adherence determinants such as 
forgetfulness, carelessness, efficacy and adverse effects. The MAQ questionnaire has been 
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validated in various patient populations and patients with cardiac conditions such as heart 
failure, CVD and dyslipidaemia (Nguyen, Caze, & Cottrell, 2014). It has demonstrated 
acceptable internal consistency of α = 0.61, sensitivity 0.81 and specificity 0.44 in patients with 
hypertension (Lavsa, Holzworth, & Ansani, 2011). The MAQ score was found to be a 
significant independent predictor of cardiovascular medication nonadherence in a multivariate 
logistic regression model (Shalansky, Levy, & Ignaszewski, 2004). 
The Adherence to Refills and Medications Scale (ARMS) (Kripalani, Risser, Gatti, & 
Jacobson, 2009) is a 12-item scale used to assess patients’ ability to self-administer and refill 
their medications. The ARMS subscales are highly correlated with the MAQ-4 items 
questionnaire, and with medication refill adherence (Kripalani et al., 2009). The ARMS has 
been validated in patients with CVD and multiple chronic conditions  and has demonstrated 
high internal consistency using Cronbach’s alpha, with α = 0.814 (Kripalani et al., 2009).   
The Belief about Medicine Questionnaire (BaMQ) (Horne et al., 1999) consists of eight 
questions used to evaluate patients’ beliefs about the necessity of medications plus concerns, 
medication overuse and general harm. The BaMQ has been shown to be a valid and reliable 
tool, correlated significantly with other medication adherence questionnaires such as MAQ and 
the Medication Adherence Rating Scale (MARS-5) (Gatti, Jacobson, Gazmararian, Schmotzer, 
& Kripalani, 2009). Each BaMQ subscale has been evaluated for internal consistency using 
Cronbach's alpha, with α values of specific-necessity=0.77, specific-concerns= 0.76, general-
overuse= 0.60, general-harm= 0.78 (Horne et al., 1999). The four BaMQ categories have been 
shown to correlate highly with patients’ beliefs about the adverse effects of medication and 
specific-concerns as assessed by the Sensitive-Soma Scale administered to general medical and 
cardiac groups to demonstrate the criterion validity of BaMQ (Horne et al., 1999). 
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The Medication Adherence Self-Efficacy Scale-Revised (MASES-R) (Fernandez, 
Chaplin, Schoenthaler, & Ogedegbe, 2008) is a 13-item questionnaire to evaluate patients’ 
confidence in taking their medications as part of everyday routine. The MASES-R has been 
shown to correlate significantly with electronic medication adherence records (MEMS) at 
three-months, confirming its predictive validity. The MASES-R has been evaluated for internal 
consistency using Cronbach's alpha, with α= 0.91 (Fernandez et al., 2008). The concurrent 
validity of the MASES-R has also been confirmed. 
The Medication Specific Social Support (MSSS) scale (Lehavot et al., 2011) is an eight-
item scale to evaluate how often patients receive support with their medication from family, 
friends, or healthcare providers (Lehavot et al., 2011). The MSSS has demonstrated high 
internal consistency using Cronbach’s alpha, with α = 0.85 (Lehavot et al., 2011). Permission 
to use these questionnaires was obtained from their authors. 
2.6 Data analysis  
Nine of the 129 questionnaires were incompleted due to missing information regarding 
medication adherence. These questionnaires were not included in the analysis (Appendix 1). 
A complete data were obtained  from 120 patients (Appendix 1). The questionnaires were 
analyzed using IBM SPSS version 23. Descriptive statistics were conducted to analyze 
patients’ socio-demographic characteristics, medication adherence values, medication 
adherence self-efficacy, beliefs about medication and social support. Among 
sociodemographic, health and medication-related data, continuous variables were presented as 
means and standard deviations, and categorical variables by frequencies and percentages 
(Table 1). Independent samples t-tests were used to analyze differences between patients with 
CVD from the cardiac rehabilitation and cardiac ward groups with continuous variables, and 
Chi-square (χ2) tests for categorical variables. Medication adherence was categorized as high, 
13 
 
medium/ low and Chi-square (χ2) was used to compare the patient groups. Bivariate analyses 
were used to examine the association between potential medication adherence factors and 
medication adherence (MAQ scale) using Spearman’s rank correlation coefficient (Rho). 
Variables significantly associated with medication adherence in these analyses were examined 
using logistic regression, reporting the odds ratios and confidence intervals for predictive 
variables. The level of significance was set at less than 0.25 for entry into regression models 
and less than 0.05 for the logistic regression test. The forced entry method was used, in which 
all potential predictors were forced into the model in the first step then sequentially removed. 
Two-sided tests were conducted with significance set at 0.05. 
3. Results 
3.1 Participants’ characteristics 
Participants’ characteristics are presented in Table 1. Most socio-demographic and health 
data did not differ significantly between participants in the two study settings. Compared to 
participants from the cardiac ward, cardiac rehabilitation participants took significantly fewer 
cardiac medications per day (Table 1). They tended to be better educated, more often employed, 
and younger, although these differences between the groups were not statistically significant 
(Table 1).  
3.2 Medication adherence 
Based on the 4-item MAQ scores, 62.5% of patients in both groups were classified as 
high (scoring 0) and 37.5% medium/low adherent (scores 1-4). Since only one patient reported 
low medication adherence, we dichotomized the dependent variable into two groups: high 
adherence (score 0) and medium/low adherence (score 1-4). Medium/low adherence rate was 
higher among participants recruited from cardiac rehabilitation rather than the cardiac ward 
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(41.9% versus 36.0%; respectively; p=0.001). Cardiac rehabilitation participants were also 
more likely to forget the names of their medications than ward participants (30.8% vs. 16.1%, 
respectively; p= 0.04). Forgetfulness was the most commonly reported reason for medication 
non-adherence (32.3% vs. 31.5% in out-patients and in-patients, respectively). Medication-
related variables (ARMS, MASES, BaMQ, MSSS) did not differ significantly between the 
groups (Table 2).  
None of the twelve sociodemographic or health variables were significantly associated 
with medication adherence, although the ability to refill medications (ARMS), medication 
adherence self-efficacy (MASES-R) and beliefs about medications (BaMQ) were all 
significantly associated with medication adherence (MAQ), demonstrating positive moderate-
strong correlations which explained 45%, 15% and 11% of patients’ medication adherence, 
respectively (Table 3). Patterns of the associations revealed similar findings when the analyze 
were conducted separately for each group. In both groups, there was a significant link between 
MAQ with ARMS and MASESR (for ward patients, Rho= 0.655, p<0.001; Rho= 0.355, 
p<0.002, respectively; for rehabilitation patients, Rho= 0.716, p<00.1; Rho= 0.498, p< 0.001, 
respectively). For ward-based participants, the association between MAQ and BaMQ just 
missed statistical significance (Rho= 0.200, p<0.06) which was demonstrated for rehabilitation 
participants (Rho= 0.696, p<0.001).  
These variables were entered in the sole binary logistic regression model that was created, 
see table 4 (Al-Ganmi et al., 2019). The results of the analysis indicated that ability to refill 
cardiac medications and beliefs about cardiac medications were significant predictors of 
cardiac medication adherence: participants with greater ability to refill cardiac medications 
(Odds ratio= 0.463, p=0.001) and with more positive beliefs about their medications were more 
likely to report better medication adherence (Odds ratio =1.142, p= 0.04). The logistic 
regression analysis recorded a significant Omnibus test for the model (significance < 0.001). 
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The Pseudo R Square statistic indicated that the model, as a whole explained between 38.7% 
(Cox & Snell R Square =0.387) and 52.8% (Nagelkerke R Square = 0.528) of the variance in 
medication adherence. ARMS + BaMQ explained 39.6% of variance but ARMS alone 
explained 36.6% of variance in MAQ. 
4. Discussion 
More than one-third of both groups had medium/low cardiac medication adherence. More 
participants recruited from cardiac rehabilitation reported medium-low medication adherence 
than those recruited as cardiac ward in-patients (41.9% versus 36.0%). Medication-related 
variables (ARMS, MASES, BaMQ, MSSS) did not differ significantly between participants 
recruited from the two settings. 
Our findings are slightly better but broadly consistent with older data from the World 
Health Organization (2003), which highlighted medication non-adherence at 50%, with 
differing predictive factors in patients with chronic and acute cardiac diseases. At 36%, these 
findings from acute cardiac patients lie within the rates reported for similar patients elsewhere: 
in studies of patients with acute myocardial infarction, where 53.6% were found to be non-
adherent to cardiac medications (Choudhry, Setoguchi, Levin, Winkelmayer, & Shrank, 2008). 
Patients referred to cardiac rehabilitation improved their adherence to cardiac medication from 
43% to 55% (Shah et al., 2009); by contrast, in this study adherence rate were worse in the 
rehabilitation setting. 
Consistent patterns of poor medication adherence in different patient groups suggests 
there may be common underlying problems, perhaps of inadequate patient education, or at least 
of patients’ inadequate understanding of the importance of medication adherence, whether at 
the initiation of therapy or latter (Woodruffe et al., 2014). Perhaps this is the result of  faulty 
beliefs, or practical or attitudinal barriers among patients attending cardiac rehabilitation 
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programs after acute cardiac events (Verburg, Selder, Schalij, Schuuring, & Treskes, 2019). 
Understanding patients’ medication adherence behaviors is the first step towards enhancing 
their self-management and improving patients’ outcomes. This study showed unacceptable 
adherence to cardiac medication in both groups, and in those recruited from the cardiac ward, 
this may have contributed to their hospital admission. The poor medication adherence reported 
by those undertaking rehabilitation indicates risk of recurrent cardiac disease and future 
hospitalization.  
The logistic regression results showed that the ability to refill and administer medications 
was significantly predictive of adherence to cardio-protective medications for both in-patient 
and rehabilitation groups. Findings are congruent with those of Kripalani et al. (2009), who 
found that patients with CVD who were better able to refill their medications and self-manage 
had better adherence to regimens. Other studies suggest that patients’ ability to refill 
medications may be linked to younger age, the number of daily medications, and patients’ 
perceptions about the complexity of their medicines and ability to self-manage (Magnabosco 
et al., 2015). The ability to refill medications in a timely manner can be affected if patients 
have lower physical activity and mobility, or if younger patients lack understanding of their 
susceptibility to CVD-related complications (Magnabosco et al., 2015). Gazmararian et al. 
(2006) indicate that individuals with multiple medications manage refills better, as they are 
more focused on management of their health and resources for managing complex 
polypharmacy are readily available. These and other findings while sometimes inconsistent 
and even contradictory, make it clear that, while patients’ ability to refill medications predicts 
medication adherence, other factors also exert significant influence in various groups. These 
findings flag the importance of examining individual patients at in-and-out patient settings and 




Like some other studies, our study found that patients with CVD from both in-patient 
and out-patient settings who held more positive beliefs about cardiac medications were more 
adherent to their medications. Several studies have found that patients’ beliefs about the 
necessity of their medication were significantly predictive of medication adherence, for 
example in-patients with acute coronary syndrome (Allen LaPointe et al., 2011) and out-
patients attending cardiac rehabilitation (Cooper, Weinman, Hankins, Jackson, & Horne, 
2007). Uncertainty about the necessity of taking medications predicts lower medication 
adherence, specifically when patients have concerns about side-effects (Horne et al., 1999). 
Patients who hold less than strong beliefs about their medications and have concerns about 
side-effects reported forgetting or deliberately skipping prescribed doses (Sabaté, 2003). Our 
findings from both settings, that positive beliefs about cardiac medications were linked to 
medication adherence, is in line with other findings and highlights an important opportunity 
for improvement.  
According to Bandura (2004), the central determinant affecting an individual’s specific 
behaviors is self-efficacy, which influences motivation and affects other determinants. 
Bivariate analyses revealed that medication self-efficacy was significantly associated with 
medication adherence, a finding consistent with the results of two cross-sectional studies of 
patients attending cardiac rehabilitation (Greer, Milner, Marcello, & Mazin, 2015). However, 
differing from the results of Morrison et al. (2015), the impact of medication self-efficacy as 
an independent predictor of medication adherence disappeared in our regression analysis. 
Perhaps this reflects different characteristics of patients and may indicate opportunities for 
cardiac ward and rehabilitation nurses and pharmacists to develop stage-specific strategies to 
promote medication self-efficacy as a way to enhance medication adherence. 
This study, like that of Wu et al. (2013), did not find sociodemographic factors 
significantly predictive of medication adherence. However, other studies have found age, for 
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example, to be significantly predictive, and significantly better medication adherence to 
hypertension medications has been noted among older people (Pamboukian et al., 2008). Given 
that the patients with CVD recruited for our study from cardiac rehabilitation were young, and 
likely to be employed and married, we might surmise that these patients had limited time and 
perhaps other activities took precedence over regular adherence to medications. Other studies 
have also been inconsistent about the effect of sociodemographic factors on medication 
adherence (Park et al., 2015).  
Medication adherence, not just prescription, should be recognized as an essential focus 
for cardiac patients, and for policy-makers. Medication adherence education and counselling 
should be prioritized for cardiac patients in all hospital settings, with education sessions and 
face-to-face counselling integrated into care plans. The reinforcement of medication 
importance during cardiac rehabilitation and in routine follow-up visits will also improve 
medication refill compliance and enhance cardiac patients’ beliefs in the necessity of taking 
their medications. Establishing medication adherence plans for patients in cardiac care settings 
will help nurses identify those who are likely to be non-adherent, and to target individual 
patients who need extra help with medication adherence. 
More attention is required to the role of cardiac nurses in assessing cardiac patients’ self-
management and ability to refill medication, and in promoting innovative forms of follow-up 
that enhance their role in cardiac rehabilitation. An effective care provider-patient relationship 
will be an important component in building an encouraging environment to achieve treatment 
plan goals. Tailoring educational interventions to target cardiac patients’ beliefs about cardiac 
medication may be an effective approach to enhance patients’ beliefs about the efficacy of 
these medications and to increase adherence to them. Simple interventions such as: electronic 
prompts, interactive packages of education, reminders through text messages or phone calls 
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using smartphone and tablet devices, all easily manageable by nurses, have been found useful 
in improving adherence to medication in patients with CVD (Ferdinand et al., 2017). 
4.1 Study limitations 
Recruiting at a single site, study results may not be generalizable. The study was 
conducted in busy clinical cardiac settings where the cardiac patients were asked to complete 
questionnaires shortly after a rehabilitation session or (in the ward) when they were deemed 
clinically stable. Tiredness may have affected the attention to the survey questions, and the 
reported medication non-adherence rates may not have been completely accurate. Cardiac 
rehabilitation was a particularly challenging location for recruitment, with staff and cardiac 
patients time-pressured and preoccupied. In spite of an adequate study size, careful 
consideration must be paid when comparing the results for different cardiac patient groups. 
Future studies could take into account the impact of clustering and sampling.  
Use of self-report questionnaires may have biased the study findings, with more socially 
acceptable but incorrect responses entered, as is the case in many studies. Use of standardized 
surveys meant participants could only provide ranked responses to the questions, and a 
qualitative enquiry providing a deeper understanding of cardiac patients’ perspectives would 
be valuable. Differences between site sample sizes may have limited our ability to determine 
significant inter-site differences. Any differences in the prescribed cardiac medications 
between acute in-patient and rehabilitation participants were not considered, which may have 
impacted patients’ adherence. Finally, as with many medication adherence studies, lack of a 





There is a need to enhance adherence to medication in patients with CVD through 
consideration of factors significantly associated with and predictive of medication adherence. 
This cross-sectional study demonstrates that ability to refill medications and positive beliefs 
about medication are independently predictive of greater cardiac medication adherence in 
patients with CVD. This suggests, first, that strategies are urgently required to improve the 
poor medication adherence demonstrated in this and other studies. Second, these strategies 
should be tailored to the factors that deter timely medication refill and to negative beliefs about 
medication adherence. Such interventions could include innovative educational interventions 
and counselling sessions by clinical nurses. Cardiac nurses have an opportunity to enhance 
their roles in assessing and improving cardiac patients’ ability to refill medication and their 
beliefs about those medications which, in turn, should improve medication adherence and 
outcomes.  
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Table 1 Sociodemographic and health characteristics of patients recruited from the cardiac rehabilitation 
department and the cardiac ward 
 
Variables Cardiac Rehab. 
n= 31 n (%)  
Cardiac Ward 

















































































































   t-test  df P-values 
Age; mean (SD)/ years  66.6 (11.9%) 69.9 (11.5) 
 
-1.38 118 0.17 
 
Years of full time education; mean (SD)  13.9 (3.6) 11.9 (3.5) 2.63 118 0.01** 
Number of cardiac medications taken 
per day; mean (SD) 
2.8 (1.1) 3.2 (0.9) 2.57 118 0.01** 









Table 2 Medication adherence-related variables in patients recruited from the cardiac rehabilitation 
department and the cardiac ward 







































Can remember all 
medications 






















    
t-test  df P-values 
ARMS mean (SD)  
 
45.10 (3.1) 45.72 (2.9) -1.000 118 0.32 
MASES mean (SD) 
 
34.06 (6.6) 35.6 (5.5) -1.282 118 0.20 
BaMQ mean (SD) 
 
30.3 (6.1) 31.9 (4.4) -1.474 118 0.14 
MSSS mean (SD) 
 
10.6 (5.6) 11.5 (7.5) -0.577 118 0.56 
MAQ individual items 











Forget to take 
Yes n (%) 










Careless at times 
Yes n (%) 










Sometimes stop taking 
when feel better 
Yes n (%) 













Sometimes stop taking 
when feel worse 
Yes n (%) 













Note: (n) number of participants, (df) degree of freedom, (SD) standard deviation, (ARMS) Ability to Refill 
Medication & Self-Management, (MASES) Medication Adherence Self-Efficacy, (BaMQ) Belief about 
Medication, (MSSS) Medication Social Support. 
MAQ level: (0) = All answers with ‘No’, (1-4) = one to four answers with ‘Yes’.  









Table 3 Associations between medication adherence (MAQ) and potential predictors 
variables in both groups participants 
Variables 
 


































Total number of pills/day  
 
-.079 0.660 
Ability to refill medication and self-management (ARMS) 
 
.676** 0.001* 
Medication adherence self-efficacy (MASES-R) 
 
.392** 0.001* 
Beliefs about medication (BaMQ) 
 
.335** 0.001* 
Medication specific social support (MSSS) 
 
-.036 0.697 
ARMS: Ability to Refill Medication & Self-Management, MASES-R: Medication Adherence Self-Efficacy, 
BaMQ: Belief about Medication, MSSS: Medication specific social support. 
**. Spearman’s rank correlation rho (odds ratio)  







Table 4 Binary logistic regression model examining predictors of cardiac medication adherence. 











Wald df Sig. Odds ratio  
Exp.(B) 












  .150   .631 .056 1 .813 1.162 .337 4.004 
ARMS 
 
0.366 0.499 -.771 .170 20.520 1 .001* .463 .332 .646 
MASERS 
 
  .000 .060 .000 1 .998 1.000 .889 1.124 
BaMQ 
 
0.396 0.539 .133 .065 4.178 1 .041* 1.142 1.005 1.298 
MAQ 0.387 0.527         
Constant   30.220 6.990 18.689 1 <0.001 133138346410.104   
a. Variable(s) entered on step 1: Age, ARMS: Ability to Refill Medication & Self-Management, MASES: Medication Adherence Self-Efficacy, BaMQ: Belief about 











Assessed for eligibility (n= 94)  
Excluded (n= 4) 
   Not meeting inclusion criteria (2) 
   Declined to participate (2) 
 
Surveys analysed (n=31) 
 










Excluded (n= 5) 
   Not meeting inclusion criteria (3) 
   Declined to participate (2) 
 







Total cardiac patients (n=120)  
Non-response rate= 
29% (n= 35) Added 
